stars 1 stars 2 stars 3

MacroCure was a biotechnology company focused on the development and commercialization of advanced cell therapy products. The company's first focus of interest is in the arena of wound care. The technology employs activated white blood cells obtained from young healthy donor blood

Macrocure Questions

The Macrocure annual revenue was $156000 in 2026.

Mitchell Shirvan is the CEO of Macrocure.

4 people are employed at Macrocure.

Macrocure is based in Petah Tiqwa, Central District.

The NAICS codes for Macrocure are [3254, 325412, 32541, 32, 325].

The SIC codes for Macrocure are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users